T1	Outcomes 18 69	safety, immunogenicity, and pharmacokinetic profile
T2	Outcomes 512 583	safety and pharmacokinetics (serum concentrations of rabies antibodies)
T3	Outcomes 1474 1500	pharmacokinetic parameters
T4	Outcomes 1574 1598	relative bioavailability
T5	Outcomes 1622 1638	absorption rates
T6	Outcomes 1714 1728	antibody level
T7	Outcomes 1794 1827	geometric mean titer (GMT) values
T8	Outcomes 1985 2008	evolution of GMT values
T9	Outcomes 2240 2257	safety evaluation
T10	Outcomes 2304 2352	serum samples for anti-rabies antibody titration
T11	Outcomes 2417 2434	serious reactions
T12	Outcomes 2484 2560	immediate (anaphylactic type) or delayed (serum sickness) allergic reactions
T13	Outcomes 2610 2622	GMT profiles
T14	Outcomes 2705 2731	protective antibody titers
T15	Outcomes 2939 2949	GMT values
T16	Outcomes 3170 3188	antibody responses
